Cargando…
The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis
BACKGROUND: Overexpression of the bZip transcription factor, ATF3, in basal epithelial cells of transgenic mice under the control of the bovine cytokeratin-5 (CK5) promoter has previously been shown to induce epidermal hyperplasia, hair follicle anomalies and neoplastic lesions of the oral mucosa in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564979/ https://www.ncbi.nlm.nih.gov/pubmed/18808719 http://dx.doi.org/10.1186/1471-2407-8-268 |
_version_ | 1782159824792846336 |
---|---|
author | Wang, Aijin Arantes, Stacey Yan, Leqin Kiguchi, Kaoru McArthur, Mark J Sahin, Aysegul Thames, Howard D Aldaz, C Marcelo MacLeod, Michael C |
author_facet | Wang, Aijin Arantes, Stacey Yan, Leqin Kiguchi, Kaoru McArthur, Mark J Sahin, Aysegul Thames, Howard D Aldaz, C Marcelo MacLeod, Michael C |
author_sort | Wang, Aijin |
collection | PubMed |
description | BACKGROUND: Overexpression of the bZip transcription factor, ATF3, in basal epithelial cells of transgenic mice under the control of the bovine cytokeratin-5 (CK5) promoter has previously been shown to induce epidermal hyperplasia, hair follicle anomalies and neoplastic lesions of the oral mucosa including squamous cell carcinomas. CK5 is known to be expressed in myoepithelial cells of the mammary gland, suggesting the possibility that transgenic BK5.ATF3 mice may exhibit mammary gland phenotypes. METHODS: Mammary glands from nulliparous mice in our BK5.ATF3 colony, both non-transgenic and transgenic, were examined for anomalies by histopathology and immunohistochemistry. Nulliparous and biparous female mice were observed for possible mammary tumor development, and suspicious masses were analyzed by histopathology and immunohistochemistry. Human breast tumor samples, as well as normal breast tissue, were similarly analyzed for ATF3 expression. RESULTS: Transgenic BK5.ATF3 mice expressed nuclear ATF3 in the basal layer of the mammary ductal epithelium, and often developed squamous metaplastic lesions in one or more mammary glands by 25 weeks of age. No progression to malignancy was seen in nulliparous BK5.ATF3 or non-transgenic mice held for 16 months. However, biparous BK5.ATF3 mice developed mammary carcinomas with squamous metaplasia between 6 months and one year of age, reaching an incidence of 67%. Cytokeratin expression in the tumors was profoundly disturbed, including expression of CK5 and CK8 (characteristic of basal and luminal cells, respectively) throughout the epithelial component of the tumors, CK6 (potentially a stem cell marker), CK10 (a marker of interfollicular epidermal differentiation), and mIRSa2 and mIRSa3.1 (markers of the inner root sheath of hair follicles). Immunohistochemical studies indicated that a subset of human breast tumors exhibit high levels of nuclear ATF3 expression. CONCLUSION: Overexpression of ATF3 in CK5-expressing cells of the murine mammary gland results in the development of squamous metaplastic lesions in nulliparous females, and in mammary tumors in biparous mice, suggesting that ATF3 acts as a mammary oncogene. A subset of human breast tumors expresses high levels of ATF3, suggesting that ATF3 may play an oncogenic role in human breast tumorigenesis, and therefore may be useful as either a biomarker or therapeutic target. |
format | Text |
id | pubmed-2564979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25649792008-10-09 The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis Wang, Aijin Arantes, Stacey Yan, Leqin Kiguchi, Kaoru McArthur, Mark J Sahin, Aysegul Thames, Howard D Aldaz, C Marcelo MacLeod, Michael C BMC Cancer Research Article BACKGROUND: Overexpression of the bZip transcription factor, ATF3, in basal epithelial cells of transgenic mice under the control of the bovine cytokeratin-5 (CK5) promoter has previously been shown to induce epidermal hyperplasia, hair follicle anomalies and neoplastic lesions of the oral mucosa including squamous cell carcinomas. CK5 is known to be expressed in myoepithelial cells of the mammary gland, suggesting the possibility that transgenic BK5.ATF3 mice may exhibit mammary gland phenotypes. METHODS: Mammary glands from nulliparous mice in our BK5.ATF3 colony, both non-transgenic and transgenic, were examined for anomalies by histopathology and immunohistochemistry. Nulliparous and biparous female mice were observed for possible mammary tumor development, and suspicious masses were analyzed by histopathology and immunohistochemistry. Human breast tumor samples, as well as normal breast tissue, were similarly analyzed for ATF3 expression. RESULTS: Transgenic BK5.ATF3 mice expressed nuclear ATF3 in the basal layer of the mammary ductal epithelium, and often developed squamous metaplastic lesions in one or more mammary glands by 25 weeks of age. No progression to malignancy was seen in nulliparous BK5.ATF3 or non-transgenic mice held for 16 months. However, biparous BK5.ATF3 mice developed mammary carcinomas with squamous metaplasia between 6 months and one year of age, reaching an incidence of 67%. Cytokeratin expression in the tumors was profoundly disturbed, including expression of CK5 and CK8 (characteristic of basal and luminal cells, respectively) throughout the epithelial component of the tumors, CK6 (potentially a stem cell marker), CK10 (a marker of interfollicular epidermal differentiation), and mIRSa2 and mIRSa3.1 (markers of the inner root sheath of hair follicles). Immunohistochemical studies indicated that a subset of human breast tumors exhibit high levels of nuclear ATF3 expression. CONCLUSION: Overexpression of ATF3 in CK5-expressing cells of the murine mammary gland results in the development of squamous metaplastic lesions in nulliparous females, and in mammary tumors in biparous mice, suggesting that ATF3 acts as a mammary oncogene. A subset of human breast tumors expresses high levels of ATF3, suggesting that ATF3 may play an oncogenic role in human breast tumorigenesis, and therefore may be useful as either a biomarker or therapeutic target. BioMed Central 2008-09-22 /pmc/articles/PMC2564979/ /pubmed/18808719 http://dx.doi.org/10.1186/1471-2407-8-268 Text en Copyright © 2008 Wang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wang, Aijin Arantes, Stacey Yan, Leqin Kiguchi, Kaoru McArthur, Mark J Sahin, Aysegul Thames, Howard D Aldaz, C Marcelo MacLeod, Michael C The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis |
title | The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis |
title_full | The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis |
title_fullStr | The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis |
title_full_unstemmed | The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis |
title_short | The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis |
title_sort | transcription factor atf3 acts as an oncogene in mouse mammary tumorigenesis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564979/ https://www.ncbi.nlm.nih.gov/pubmed/18808719 http://dx.doi.org/10.1186/1471-2407-8-268 |
work_keys_str_mv | AT wangaijin thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT arantesstacey thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT yanleqin thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT kiguchikaoru thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT mcarthurmarkj thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT sahinaysegul thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT thameshowardd thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT aldazcmarcelo thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT macleodmichaelc thetranscriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT wangaijin transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT arantesstacey transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT yanleqin transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT kiguchikaoru transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT mcarthurmarkj transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT sahinaysegul transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT thameshowardd transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT aldazcmarcelo transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis AT macleodmichaelc transcriptionfactoratf3actsasanoncogeneinmousemammarytumorigenesis |